Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium

Alison M Mondul, Irene M Shui, Kai Yu, Ruth C Travis, Victoria L Stevens, Daniele Campa, Frederick R Schumacher, Regina G Ziegler, H Bas Bueno-de-Mesquita, Sonja Berndt, E D Crawford, Susan M Gapstur, J Michael Gaziano, Edward Giovannucci, Christopher A Haiman, Brian E Henderson, David J Hunter, Mattias Johansson, Timothy J Key, Loïc Le MarchandSara Lindström, Marjorie L McCullough, Carmen Navarro, Kim Overvad, Domenico Palli, Mark Purdue, Meir J Stampfer, Stephanie J Weinstein, Walter C Willett, Meredith Yeager, Stephen J Chanock, Dimitrios Trichopoulos, Laurence N Kolonel, Peter Kraft, Demetrius Albanes

Research output: Contribution to journalJournal articleResearchpeer-review

30 Citations (Scopus)

Abstract

Studies suggest that vitamin D status may be associated with prostate cancer risk although the direction and strength of this association differs between experimental and observational studies. Genome-wide association studies have identified genetic variants associated with 25-hydroxyvitamin D [25(OH)D] status. We examined prostate cancer risk in relation to single-nucleotide polymorphisms (SNP) in four genes shown to predict circulating levels of 25(OH)D.
Original languageEnglish
JournalCancer Epidemiology, Biomarkers & Prevention
Volume22
Issue number4
Pages (from-to)688-96
Number of pages9
ISSN1055-9965
DOIs
Publication statusPublished - Apr 2013

Fingerprint

Dive into the research topics of 'Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium'. Together they form a unique fingerprint.

Cite this